Skip to content

Drug interactions

Crizotinib + Danicopan

Severity: Moderate

Crizotinib and Danicopan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits P-glycoprotein and may increase crizotinib exposure. This may heighten crizotinib adverse effects including hepatotoxicity and QT prolongation.

What this interaction means in plain words

Crizotinib and Danicopan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Danicopan belongs to Miscellaneous.

Evidence level: Low

Why it happens

Danicopan inhibits P-gp efflux, increasing crizotinib bioavailability.

What to do

Monitor for crizotinib toxicity, including liver tests and ECG. Consider a crizotinib dose reduction if adverse effects appear.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Danicopan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Danicopan?

MediHelp rates the interaction as moderate. Crizotinib and Danicopan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits P-glycoprotein and may increase crizotinib exposure. This may heighten crizotinib adverse effects including hepatotoxicity and QT prolongation.

How serious is the interaction between Crizotinib and Danicopan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for crizotinib toxicity, including liver tests and ECG. Consider a crizotinib dose reduction if adverse effects appear.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in